{
    "nctId": "NCT04511832",
    "briefTitle": "Comparative Effectiveness of Acupuncture and Nonsteroidal Anti-inflammatory Drugs for the Management of Aromatase Inhibitor Induced Arthralgia Among Breast Cancer Survivors",
    "officialTitle": "Comparative Effectiveness of Acupuncture and Nonsteroidal Anti-inflammatory Drugs for the Management of Aromatase Inhibitor Induced Arthralgia Among Breast Cancer Survivors",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 54,
    "primaryOutcomeMeasure": "Acupuncture can improve joint symptoms resulting from aromatase inhibitor and quality of life",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women who were postmenopausal aged more than 20 years old.\n* history of stage 0 to III hormone receptor-positive breast cancer, and currently taking a third-generation AI (anastrozole, letrozole, or exemestane) for at least 3 month.\n* Those who reported pain and/or stiffness in one or more joints, which started or worsened after initiation of AI therapy had worst joint pain rated at least three or greater on a 0-10 numerical rating scale in the preceding week.\n\nExclusion Criteria:\n\n* any prior acupuncture use for AI-induced joint symptoms or acupuncture within 1 months before entry\n* inflammatory, metabolic, or neuropathic arthropathies\n* bone fracture/surgery of an afflicted extremity during the preceding 6 months\n* allergy to NSAID\n* current use of narcotics\n* bleeding or coagulation disorders\n* localized skin infections\n* needle phobia\n* intra-articular corticosteroid within 4 weeks preceding the study\n* any severe chronic or uncontrolled comorbid disease",
    "sex": "ALL",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}